ArticleThe Lancet. Infectious diseases2020

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.

Till Koch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.